International models of investigator-initiated trials: implications for Japan

Edward L. Trimble,Jonathan A. Ledermann,K. Law,T. Miyata,Chiyo K. Imamura,B. H. Nam,Y.H. Kim,Yung-Jue Bang,Margo Michaels,D. Ardron,S. Amano,Yuichi Ando,T. Tominaga,K. Kurokawa,Naoko Takebe

International models of investigator-initiated trials: implications for Japan

2012

Edward L. Trimble
Jonathan A. Ledermann
K. Law
T. Miyata
Chiyo K. Imamura
B. H. Nam
Y.H. Kim
Yung-Jue Bang
Margo Michaels
D. Ardron
S. Amano
Yuichi Ando
T. Tominaga
K. Kurokawa
Naoko Takebe

Background Academic/institutional investigator-initiated clinical trials benefit individuals and society by supplementing gaps in industry-sponsored clinical trials.

Keywords:

Clinical trial
Good clinical practice
Alternative medicine
Academia (organization)
Investigational New Drug Application
Medicine
Health care
Family medicine
Clinical Practice
Sociology of scientific knowledge
drug approval
General surgery
Pharmacology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations